In line with this hypothesis, two recent studies have demonstrated that enhanced activity of sEH increases the severity of the ischemia-reperfusion injury in the kidney [14] and is also associated with more advanced endothelial dysfunction [33], which are common complications in kidney transplantation [34]. Here, EPHX2 is linked to endothelial dysfunction.